Loss to Follow-Up: Patients with Type 1 Diabetes During the SARS-CoV-2 Pandemic.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Skelly E; Tognolini D
  • Source:
    Pediatric annals [Pediatr Ann] 2024 Jul; Vol. 53 (7), pp. e254-e257. Date of Electronic Publication: 2024 Jul 01.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Slack Country of Publication: United States NLM ID: 0356657 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-2359 (Electronic) Linking ISSN: 00904481 NLM ISO Abbreviation: Pediatr Ann Subsets: MEDLINE
    • Publication Information:
      Publication: Thorofare NJ : Slack
      Original Publication: New York, Insight Pub. Co.
    • Subject Terms:
      Diabetes Mellitus, Type 1*/epidemiology ; Diabetes Mellitus, Type 1*/complications ; COVID-19*/epidemiology; Humans ; Child ; Lost to Follow-Up ; SARS-CoV-2
    • Abstract:
      The SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2) pandemic revealed many flaws in our health care system. This review aims to explore the significance of loss to follow-up on patients with type 1 diabetes during the pandemic, the morbidity and mortality associated, and strategies to prevent loss to follow-up or to re-engage patients in longitudinal care. [ Pediatr Ann . 2024;53(7):e254-e257.] .
    • Publication Date:
      Date Created: 20240701 Date Completed: 20240701 Latest Revision: 20240701
    • Publication Date:
      20240702
    • Accession Number:
      10.3928/19382359-20240502-04
    • Accession Number:
      38949871